HOT-TAKE

A collection of 52 posts

Paid-members only

Start-Upomics

The Grail/Illumina Class-Action lawsuit gets a juicy update

Paid-members only

Start-Upomics

Tempus' good very bad week included a $410m IPO, a lawsuit and a ~$20 swing in their post-IPO stock price

Paid-members only

High-Throughput Sequencing

If you thought the sequencing wars were hot already, have you considered what a $10 genome might do to them?

Paid-members only

Start-Upomics

Who's prioritizing bringing the next generation of sequencing technology to the clinic? The answer might surprise you.

Paid-members only

Start-Upomics

Grail might have been too bold a choice for a company name

Paid-members only

High-Throughput Sequencing

Another summer of sequencing is upon us. Whose sparkle will beguile the hearts of suitors and dazzle the eyes of onlookers?

Paid-members only

Hype Cycles

AlphaFold, the second coming of Christ or just another useful tool in the life sciences?

Paid-members only

Genomic Sequencing

Spatial omics (and other creative applications) might give that dying NovaSeq of yours a second life!

Paid-members only

FDA

Did the FDA chicken out with its push to regulate lab developed tests? Kinda.

Paid-members only

Genetics

What happens if insurance companies start using your genetic data against you?

Paid-members only

Genomics Featured

Pacific Biosciences drops nearly 50% after a bad earnings report and a mind-boggling update to their product roadmap

Paid-members only

DNA

Oncology screening might be hitting its stride

Paid-members only

Start-Upomics Featured

Bionano Genomics recently announced it was laying off 1/3rd of its workforce

Paid-members only

Start-Upomics Featured

Reports of NanoString's death appear to have been severely overstated

Paid-members only

Genomic Sequencing Featured

Illumina ruffled some feathers this week with a video appeal to moderate sized "core labs"

Paid-members only

Start-Upomics Featured

Francis deSouza is back from his post-Illumina purgatory with a new AI start-up

Paid-members only

Genomics Featured

Complete Genomics wants America to give them a second chance. Should they?

Paid-members only

Start-Upomics Featured

Is the life sciences bankruptcy bloodbath waxing or waning? Let's hope Nanostring and Invitae aren't emblematic of what's to come!

Paid-members only

Conferenceomics Featured

There was a lot of 'omics sizzle at this years' AGBT, and I'm not talking about the wicked sun-burns

Paid-members only

Illumina Featured

Add open-source sequencers to the list of things short-read manufacturers have to deal with now

Paid-members only

Illumina Featured

Is spatial-omics the new sequencing land-grab?

Paid-members only

Start-Upomics Featured

RavGen got Natera to cough up $57m. What's going on with non-invasive screening test IP?

Paid-members only

Conferenceomics Featured

A round-up of everything omics that happened at the JP Morgan Healthcare Conference

Paid-members only

Start-Upomics Featured

23andMe has been in the news recently about a data breach, raising important questions about data security in the age of genomics

Paid-members only

Proteomics Featured

It was a bad week for plasma proteomics darlings Olink and SomaLogic